|  | Mucosal thickening |  | |||
---|---|---|---|---|---|---|
Parameters | n | 2–4 |  > 4 to ≤ 10 |  > 10 mm | p | |
Gender | Â | Â | Â | Â | 0.251 | |
 Male | 114 (56.2%) | 14 (6.9%) | 53 (26.1%) | 47 (23.2%) |  | |
 Female | 89 (43.8%) | 15 (7.4%) | 47 (23.2%) | 27 (13.3%) |  | |
Age | Â | Â | Â | Â | 0.139 | |
 < 44 | 44 (21.7%) | 2 (1.0%) | 24 (11.8%) | 18 (8.9%) |  | |
 44–64 | 114 (56.2%) | 19 (9.4%) | 51 (25.1%) | 44 (21.7%) |  | |
 ≥ 65 | 45 (22.2%) | 8 (3.9%) | 25 (12.3%) | 12 (5.9%) |  | |
Molar site | Â | Â | Â | Â | 0.572 | |
 First molar | 127 (62.6%) | 18 (8.9%) | 66 (32.5%) | 43 (21.2%) |  | |
 Second molar | 76 (37.4%) | 11 (5.4%) | 34 (16.7%) | 31 (15.3%) |  | |
Furcation lesion | Â | Â | Â | Â | 0.038 | |
 Calss 0 | 91 (44.8%) | 13 (6.4%) | 52 (25.6%) | 26 (12.85%) |  | |
 Class I | 34 (16.7%) | 5 (2.5%) | 12 (5.9%) | 17 (8.4%) |  | |
 Class II | 49 (24.1%) | 9 (4.4%) | 26 (12.8%) | 14 (6.9%) |  | |
 Class III | 29 (14.3%) | 2 (1.0%) | 10 (4.9%) | 17 (8.4%) |  | |
Vertical infro-bony defects | Â | Â | Â | Â | 0.863 | |
 Type I | 48 (23.6%) | 8 (3.9%) | 25 (12.3) | 15 (7.4%) |  | |
 Type II | 81 (39.9%) | 12 (5.9%) | 40 (19.7%) | 29 (14.3%) |  | |
 Type III | 74 (36.5%) | 9 (4.4%) | 35 (17.2%) | 30 (14.8%) |  | |
MinRABH | Â | Â | Â | Â | 0.031* | |
 < 4 | 96 (47.3%) | 9 (4.4%) | 42 (20.7%) | 45 (22.2%) |  | |
 4–10 | 91 (44.8%) | 17 (8.4%) | 48 (23.6%) | 26 (12.8%) |  | |
 ≥ 10 | 16 (7.9%) | 3 (1.5%) | 10 (4.9%) | 3 (1.5%) |  | |
ABL | Â | Â | Â | Â | 0.000*** | |
 Mild | 101 (49.8%) | 23 (11.3%) | 55 (27.1%) | 23 (11.3%) |  | |
 Moderate | 69 (34.0%) | 4 (2.0%) | 32 (15.8%) | 33 (16.3%) |  | |
 Severe | 33 (16.3%) | 2 (1.0%) | 13 (6.4%) | 18 (8.9%) |  |